Synlogic

Synlogic

Powering the microbiome with synthetic biotics

Human health & social work | United States of America | Disease Specific Prevention and Mitigation |

 Profile Provided By: Company Website

Overview

Synlogic Inc. a biopharmaceutical company offers synthetic biotics that perform specific metabolic functions from the gut microbiome to correct missing or dysfunctional metabolic activities throughout the body. It provides SYNB1010 for urea cycle disorder a synthetic biotic that is designed to remove excess ammonia from the blood and SYNB2010 for phenylketonuria a synthetic biotic that is designed to remove excess phenylalanine from the blood. The company was formerly known as TMC Therapeutics Inc. and changed its name to Synlogic Inc. in March 2014. Synlogic Inc.

Industry

Legal Structure

Operating Status

Employees

Human health & social work Operating 11 - 50 employees

Funding and Financing Rounds


Team


Impact

Social Objectives:

Environmental Objectives:

Operational Impact:


Impact Reports & Metrics


Offices

Headquarters

200 Sidney St.
Suite 320
Cambridge, Massachusetts 02139
United States of America



Explore

Revision History


Quick Search



  • Global  
  • Africa  
  • Americas  
  • Asia  
  • Europe  
  • Oceania  


News & Links

Incoming

Tags

COPYRIGHT 2017 IMPACTSPACE. ALL RIGHTS RESERVED.